Clinical trial / 2013
Mentha spicata and Mentha × piperita essential oils significantly reduced chemotherapy-induced nausea and vomiting without adverse effects.
In a randomized, double-blind clinical trial, patients were assigned to receive Mentha spicata, Mentha × piperita, placebo, or a control condition continuing their previous antiemetic regimen (50 courses analysed per group). Both mint essential oil groups experienced a significant reduction in the intensity and number of emetic events in the first 24 hours compared with the control (p < 0.05). No adverse effects were reported, and the cost of treatment was also reduced when essential oils were used.
- Study type
- Randomized, double-blind clinical trial
- Who was studied
- Chemotherapy patients (50 courses analysed per group)
- What was measured
- Emetic events, nausea intensity over 20 h, adverse effects, treatment cost
THE PAPER
Antiemetic activity of volatile oil from Mentha spicata and Mentha × piperita in chemotherapy-induced nausea and vomiting.
Tayarani-Najaran Z, Talasaz-Firoozi E, Nasiri R, Jalali N, Hassanzadeh M. Ecancermedicalscience, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.